CooperSurgical Fertility Solutions
CooperSurgical Fertility Solutions is a women's health and fertility medical device company serving hospitals, fertility clinics, and OB/GYN practices with IUDs, ART media, surgical instruments, diagnostics, and cryopreservation services through subsidiaries California Cryobank, Donor Egg Bank USA, and CBR.
- Company typePrivate
- Founded1989
- HeadquartersBallerup, Denmark
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What CooperSurgical Fertility Solutions does
CooperSurgical Fertility Solutions is a U.S.-headquartered (Trumbull, CT) women's health and fertility medical device company operating as a wholly-owned subsidiary of CooperCompanies (NYSE: COO). The company distributes a broad portfolio of regulated medical devices and consumables used by hospitals, fertility clinics, and OB/GYN practices, including the Paragard intrauterine device, ART media and consumables for IVF procedures, gynecological surgical retractors and instruments (RUMI II, Lone Star, ALLY II UPS, Advincula Delineator, ONETRAC LX, INSORB Skin Stapler, Doppler Blood Flow Monitor), and the Endosee Advance office-based uterine diagnostic system.
Beyond hardware, CooperSurgical operates vertically integrated reproductive tissue and stem cell service businesses through wholly-owned subsidiaries — California Cryobank (sperm and egg banking), Donor Egg Bank USA (donor eggs), and Core Blood Registry (newborn cord blood and tissue storage) — generating recurring, contract-based service revenue alongside device sales. The portfolio was most recently extended in 2024 with the acquisition of ZyMōt Fertility from DxNow, Inc., adding sperm-selection technology to the ART device line.
The business model combines multi-year enterprise contract sales to healthcare facilities (medical device hardware, ART consumables, and equipment service contracts) with consumer-facing cryopreservation and stem cell storage services. Distribution is primarily direct via an enterprise field sales force serving clinical accounts, complemented by a B2B e-commerce storefront, dedicated healthcare provider and patient portals, and global training and medical education programs. Pricing is quote-based and not publicly disclosed. Quality operations adhere to FDA 21 CFR Part 820, ISO 13485, and cGMP standards. Founded around 1989 and active for nearly 35 years, CooperSurgical operates with 1,001-5,000 employees, primarily in North America, and is one of the established diversified players in the women's health and reproductive medicine market.
CooperSurgical Fertility Solutions firmographics
Firmographics- Name
- CooperSurgical Fertility Solutions
- Legal name
- CooperSurgical, Inc.
- Website
- https://fertility.coopersurgical.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- CooperSurgical Fertility Solutions is a women's health and fertility medical device company serving hospitals, fertility clinics, and OB/GYN practices with IUDs, ART media, surgical instruments, diagnostics, and cryopreservation services through subsidiaries California Cryobank, Donor Egg Bank USA, and CBR.
- Ownership category
- akta.pro rank
CooperSurgical Fertility Solutions industry classification
Industry- Product category
- Women's Health and Fertility Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where CooperSurgical Fertility Solutions is headquartered
LocationHeadquarters
- HQ city
- Ballerup
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
CooperSurgical Fertility Solutions business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Sale of fertility equipment, ART media, surgical instruments, and contraceptive devices to healthcare providers and facilities
- Fertility Preservation Services: Cryopreservation services for reproductive cells and tissues through subsidiary brands including California Cryobank and Donor Egg Bank USA
- Stem Cell Banking: Newborn stem cell collection and storage services through Core Blood Registry (CBR)
- Service and Support: Preventative maintenance, spare parts, product training, and warranty services for medical equipment
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based enterprise pricing for healthcare facilities |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CooperSurgical Fertility Solutions product offering
Product offeringCore offering
CooperSurgical Fertility Solutions manufactures, distributes, and services medical devices, surgical instruments, and consumables used in fertility treatments (including IVF/ART), labor and delivery, gynecological surgery, and women's reproductive healthcare. The company also provides cryopreservation, donor gamete, and newborn stem cell banking services through wholly-owned subsidiary brands (California Cryobank, Donor Egg Bank USA, Core Blood Registry).
Product overview
CooperSurgical is a diversified women's health and fertility company offering a broad portfolio of products and services across reproductive care, fertility, birth, and women's health. The portfolio includes core contraceptive devices (Paragard), acquired fertility preservation brands (California Cryobank, Donor Egg Bank USA, Core Blood Registry), ART equipment and consumables, labor and delivery solutions, gynecological surgical instruments (RUMI II, Lone Star, ALLY II UPS, Advincula Delineator, ONETRAC LX, INSORB Skin Stapler, Doppler Blood Flow Monitor), diagnostic systems (Endosee Advance System), and genomics services. Recent acquisition of ZyMōt Fertility from DxNow, Inc. has further expanded their assisted reproductive technology offerings. The company also provides automated billing services through Embryo Options and patient portal access via the Genomics Results Portal.
Differentiator
Problem solved
Functional benefit
Brands
- Paragard: Contraception product (IUD)
- California Cryobank
- Donor Egg Bank USA
- Core Blood Registry (CBR)
- Endosee Advance System
- ZyMōt Fertility
Products and services
- Paragard Intrauterine contraceptive device providing long-acting reversible contraception for women.
- California Cryobank Sperm and egg cryobank providing donor sperm, donor eggs, and fertility preservation services.
- Donor Egg Bank USA National donor egg bank offering frozen donor eggs for fertility treatment.
- Core Blood Registry (CBR) Newborn stem cell banking service for cord blood and cord tissue storage.
- Embryo Options Automated cryo storage billing system for managing embryo storage payments.
- Endosee Advance System Handheld device for office-based uterine health diagnostics enabling in-clinic procedures.
- RUMI II Surgical retractor system used in gynecological procedures.
- Lone Star Self-retaining surgical retractor system for gynecological and other surgical procedures.
- ALLY II UPS Surgical device for uterine positioning in gynecological procedures.
- Advincula Delineator Surgical instrument for delineating uterine anatomy during procedures.
- ONETRAC LX Laparoscopic surgical system for minimally invasive gynecological procedures.
- INSORB Skin Stapler Absorbable skin stapler for closing surgical incisions.
- Doppler Blood Flow Monitor Device for monitoring blood flow during surgical procedures.
- Genomics Results Portal Patient portal for accessing genomics test results from reproductive genetic screening.
Quantifiable outcome
- Serving healthcare providers and patients with comprehensive women's health solutions
Companies that use CooperSurgical Fertility Solutions
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
CooperSurgical Fertility Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
CooperSurgical Fertility Solutions partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DxNow, Inc.acquisitionCooperSurgical acquired ZyMōt Fertility, a subsidiary of DxNow, Inc., expanding its portfolio of fertility solutions and devices.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
CooperSurgical Fertility Solutions competitors and assessment
Company assessmentEmerging players
- Cryoport: Cryoport provides cryogenic cold-chain logistics and storage for reproductive cells and tissues. It is comparable to CooperSurgical's California Cryobank and Core Blood Registry businesses in the cryopreservation and biobanking value chain.
- Genea Biomedx: Genea Biomedx develops ART devices and consumables (e.g., benchtop incubators, lab automation). It overlaps with CooperSurgical's ART equipment line and represents a more focused, emerging competitor in IVF lab tooling.
Direct peers
- Hamilton Thorne: Hamilton Thorne manufactures precision instruments and disposables for ART clinics, including laser systems and micromanipulators. It overlaps with CooperSurgical's ART equipment and consumables lines and sells into the same IVF lab buyer.
- Esco Medical: Esco Medical produces benchtop incubators, time-lapse imaging, and ART devices for IVF clinics. It competes directly with CooperSurgical's ART equipment portfolio and is sold into the same embryology lab buyer.
- Vitrolife: Vitrolife is one of the largest global suppliers of ART media, consumables, and devices for IVF clinics. It directly competes with CooperSurgical's Assisted Reproductive Technology portfolio (media, devices, consumables) and targets the same fertility clinic and lab customer base.
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific supplies ART media, vitrification kits, and culture supplies for IVF labs. It directly competes with CooperSurgical's ART media and consumables offering and serves the same fertility clinic and embryology lab market.
Broad incumbents
- CooperVision: CooperVision is the sister division of CooperSurgical under CooperCompanies (NYSE: COO), focused on contact lenses. It is comparable as a sibling segment of the same publicly traded parent and shares corporate infrastructure, capital allocation, and strategic oversight.
- Merck KGaA (Life Science / Sigma-Aldrich): Merck's life science arm supplies cell culture media, buffers, and lab consumables used throughout IVF and assisted reproduction workflows. It competes with CooperSurgical's ART media and consumables at the lab-buyer level as part of a much broader life science portfolio.
- Boston Scientific: Boston Scientific is a large diversified medical device maker with products in gynecology and surgical retractor/instrument categories. It is a broad incumbent that overlaps with CooperSurgical's gynecological surgical instruments (RUMI II, Lone Star) and women's care portfolio.
- Hologic: Hologic is a women's health-focused device company spanning diagnostics, surgical, and screening. It overlaps with CooperSurgical's gynecological surgery and diagnostic systems lines (e.g., Endosee Advance) as a broader incumbent in women's health.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CooperSurgical Fertility Solutions social profiles
Digital presenceCooperSurgical Fertility Solutions compliance and trust
Trust signalCompliance2 records
CooperSurgical Fertility Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
CooperSurgical Fertility Solutions leadership team
Management profileNumber of profiles
CooperSurgical Fertility Solutions subsidiaries and ownership
Company hierarchySubsidiaries4 records
CooperSurgical Fertility Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CooperSurgical Fertility Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CooperSurgical Fertility Solutions
What does CooperSurgical Fertility Solutions do?
CooperSurgical Fertility Solutions manufactures, distributes, and services medical devices, surgical instruments, and consumables used in fertility treatments (including IVF/ART), labor and delivery, gynecological surgery, and women's reproductive healthcare. The company also provides cryopreservation, donor gamete, and newborn stem cell banking services through wholly-owned subsidiary brands (California Cryobank, Donor Egg Bank USA, Core Blood Registry).
Is CooperSurgical Fertility Solutions a public or private company?
CooperSurgical Fertility Solutions is a private company. It is classified as corporate owned and is currently operating.
When was CooperSurgical Fertility Solutions founded?
CooperSurgical Fertility Solutions was founded in 1989. It employs 1,001 to 5,000 people.
Where is CooperSurgical Fertility Solutions based?
CooperSurgical Fertility Solutions is headquartered in Ballerup, Denmark, in the Europe region.
How does CooperSurgical Fertility Solutions make money?
Four revenue lines are on record. Medical Device Sales are the primary driver. The others are fertility Preservation Services, stem Cell Banking and service and Support.
Who are CooperSurgical Fertility Solutions's main competitors?
Emerging players on record are Cryoport and Genea Biomedx. Direct peers are Hamilton Thorne, Esco Medical, Vitrolife and FUJIFILM Irvine Scientific. Broad incumbents are CooperVision, Merck KGaA (Life Science / Sigma-Aldrich), Boston Scientific and Hologic.
Does CooperSurgical Fertility Solutions have an API?
No public API is recorded for CooperSurgical Fertility Solutions.
What industry is CooperSurgical Fertility Solutions in?
CooperSurgical Fertility Solutions's product category is Women's Health and Fertility Medical Devices. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 339113 and its SIC code is 3841.